5 completed. 5 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 5 |
Follow Developmental Disabilities: new trials by email Literature Review of Developmental Disabilities trials Research Report on Developmental Disabilities
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial of Melatonin to Improve Sleep in Children With Epilepsy and Neurodevelopmental Disabilities Fast Release Melatonin (FR MLT), Fast Release Placebo, Timed Release Melatonin (TR MLT) - Epilepsy, Insomnia | Phase 3 | Completed | The Hospital for Sick Children | 13 | 2010-07-01 | 2014-12-02 |
| Supporting the Well Being of Families of Young Children With Autism Spectrum Disorders Problem Solving Education - Maternal Depression | Phase 3 | Completed | Boston Medical Center | 122 | 2009-09-01 | 2013-04-29 |
| Caffeine for Apnea of Prematurity (CAP) Caffeine citrate injection - Apnea of Prematurity | Phase 3 | Completed | McMaster University | 2000 | 1999-10-01 | 2018-03-22 |
| A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Children With Autistic Disorder and Other Pervasive Developmental Disorders (PDD) risperidone - DCild Development Disorders, Pervasive, Autistic Disorder | Phase 3 | Completed | Janssen-Ortho Inc., Canada | 80 | 1999-08-01 | 2011-01-24 |
| Atypical Neuroleptic Drugs in People With Mental Retardation/Developmental Delay risperidone, clozapine, olanzapine - Mental Retardation, Developmental Delay Disorder | Phase 3 | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 50 | 1998-07-01 | 2005-06-24 |
Apnea (1) · Asperger Syndrome (1) · Autistic Disorder (1) · Child Development Disorders, Pervasive (1) · Depression (1) · Epilepsy (1) · Intellectual Disability (1) · Mental Disorders (1) · Rett Syndrome (1) · Sleep Initiation and Maintenance Disorders (1)
Neurodevelopmental Disorders (5) · Mental Disorders (4) · Nervous System Diseases (3) · Neurobehavioral Manifestations (2) · Neurologic Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Autism Spectrum Disorder (1) · Behavior (1) · Behavioral Symptoms (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Dyssomnias (1) · Genetic Diseases, Inborn (1)
Risperidone (2) · Clozapine (1) · Olanzapine (1) · caffeine citrate (1)
Boston Medical Center (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · Janssen-Ortho Inc., Canada (1) · McMaster University (1) · The Hospital for Sick Children (1)
United States (3) · Canada (2) · Australia (1) · Germany (1) · Israel (1) · Netherlands (1) · Sweden (1) · Switzerland (1) · United Kingdom (1)
Alfonso Solimano, MD (1) · Arne Ohlsson, MD (1) · Barbara K Schmidt, MD (1) · Deborah Dewey, MD (1) · Diane Moddemann, MD (1) · Elizabeth Asztalos, MD (1) · Keith J Barrington, MD (1) · Lex Doyle, MD (1) · Peter Anderson, PhD (1) · Peter Davis, MD (1) · Robin S Roberts, MTech (1) · Ruth Grunau, MD (1) · Shelly Weiss, MD (1) · Stephen Schroeder, PhD (1)
PMID 15492353, PMID 16707748, PMID 17989382, PMID 19926098, PMID 21173002, PMID 22253394, PMID 24217336, PMID 24496539, PMID 24840756, PMID 25641237, PMID 25784749, PMID 28437520, PMID 28707987
P01HD026927 (1)